AP Gets First Notified Body for Medical Device Manufacturing Facilities Inspection

CDSCO has notified KIHT Certification Services (KCS) inside AMTZ as state’s first regulatory body

Visakhapatnam: Andhra Pradesh is now home to its first-ever CDSCO notified auditing body for medical devices. In a significant move, the Central Drugs Standard Control Organisation (CDSCO) under Minister of Health and Family Welfare, Govt. of India has notified KIHT Certification Services (KCS) as the state’s first regulatory body authorised to inspect manufacturing facilities for Class A and Class B medical devices.

Among 14 such notified bodies nationwide, KCS is the only one operational in Andhra Pradesh and Telangana, marking a milestone in the region’s quality management capabilities. Founded in July 2017, Kalam Institute of Health Technology (KIHT) housed inside the AMTZ campus is a Government of India project supported by the Department of Biotechnology, at promoting and supporting innovations in medical technologies through research and development, industry promotion, policy-making and knowledge repository.

Founded in April 2022, KCS is accredited by the National Accreditation Board for Certification Bodies (NABCB) under ISO/IEC 17021 1:2015 and IAF MD 9:2023 standards. The organisation offers comprehensive services including ISO 13485 certification, quality systems audits, risk management training, and CE mark consultancy—making it a full-service hub for manufacturers seeking to meet global regulatory standards.

This approval brings immediate benefits to domestic manufacturers, particularly MSMEs, by eliminating the need for audits outside the state—resulting in significant time and cost savings. It also reinforces Andhra Pradesh’s MedTech credentials, supporting national campaigns like “Make in India” and “ACI manufacturing,” while making the region highly attractive for future investments. This significant milestone empowers KCS to conduct independent regulatory audits for medical device manufacturers in accordance with the Medical Devices Rules (MDR) 2017 for Class A (low risk) and Class B (moderate risk), the state underscores its reputation as a business-friendly hub, ready to meet rising global demand in healthcare.

Related Posts

4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

Meerut: A four-year-old boy’s condition allegedly worsened after he was administered an anti-rabies injection at Sambhal district hospital following a snakebite. A pharmacist at the hospital has been removed from…

Lupin gets tentative US FDA nod for apixaban oral suspension for patients who cannot swallow tablets

Once final approval comes through, the liquid anticoagulant will be made at Lupin’s plant in Somerset, New Jersey, the company said. Mumbai: Lupin has received tentative approval from the US…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore

Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore